Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 1
1994 5
1995 8
1996 7
1997 7
1998 10
1999 12
2000 12
2001 9
2002 21
2003 20
2004 15
2005 34
2006 43
2007 60
2008 86
2009 115
2010 143
2011 207
2012 262
2013 290
2014 316
2015 305
2016 322
2017 290
2018 270
2019 150
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

2,632 results
Results by year
Filters applied: . Clear all
Page 1
Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis.
Dahl SL, Woodworth JS, Lerche CJ, Cramer EP, Nielsen PR, Moser C, Thomsen AR, Borregaard N, Cowland JB. Dahl SL, et al. Front Immunol. 2018 Nov 26;9:2717. doi: 10.3389/fimmu.2018.02717. eCollection 2018. Front Immunol. 2018. PMID: 30534124 Free PMC article.
Lipocalin-2 derived from adipose tissue mediates aldosterone-induced renal injury.
Sun WY, Bai B, Luo C, Yang K, Li D, Wu D, Félétou M, Villeneuve N, Zhou Y, Yang J, Xu A, Vanhoutte PM, Wang Y. Sun WY, et al. JCI Insight. 2018 Sep 6;3(17):e120196. doi: 10.1172/jci.insight.120196. eCollection 2018 Sep 6. JCI Insight. 2018. PMID: 30185654 Free PMC article.
Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation.
Xiao X, Yeoh BS, Vijay-Kumar M. Xiao X, et al. Annu Rev Nutr. 2017 Aug 21;37:103-130. doi: 10.1146/annurev-nutr-071816-064559. Epub 2017 Jun 19. Annu Rev Nutr. 2017. PMID: 28628361 Review.
Hepatorenal syndrome.
Ginès P, Solà E, Angeli P, Wong F, Nadim MK, Kamath PS. Ginès P, et al. Nat Rev Dis Primers. 2018 Sep 13;4(1):23. doi: 10.1038/s41572-018-0022-7. Nat Rev Dis Primers. 2018. PMID: 30213943 Review.
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Gomez-Chou SB, Swidnicka-Siergiejko AK, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, Deng D, Hwang RF, Zhou L, Moore T, Chatterjee D, Wang H, Leng X, Arlinghaus RB, Logsdon CD, Cruz-Monserrate Z. Gomez-Chou SB, et al. Cancer Res. 2017 May 15;77(10):2647-2660. doi: 10.1158/0008-5472.CAN-16-1986. Epub 2017 Mar 1. Cancer Res. 2017. PMID: 28249896 Free PMC article.
Holo-lipocalin-2-derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytes.
Song E, Ramos SV, Huang X, Liu Y, Botta A, Sung HK, Turnbull PC, Wheeler MB, Berger T, Wilson DJ, Perry CGR, Mak TW, Sweeney G. Song E, et al. Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1576-1581. doi: 10.1073/pnas.1720570115. Epub 2018 Jan 29. Proc Natl Acad Sci U S A. 2018. PMID: 29378951 Free PMC article.
Lipocalin-2 abrogates epithelial cell cycle arrest by PPARγ inhibition.
Jung M, Brüne B, von Knethen A, Guiteras R, Cruzado JM, Hotter G, Sola A. Jung M, et al. Lab Invest. 2018 Nov;98(11):1408-1422. doi: 10.1038/s41374-018-0098-4. Epub 2018 Aug 7. Lab Invest. 2018. PMID: 30087458 Free article.
2,632 results
Jump to page
Feedback